Understanding Virbac's Share Capital and Voting Rights
Virbac is a leading player in the field of animal health, renowned for its dedication to enhancing pet care and livestock management. In the spirit of transparency, the company regularly provides updates on its share capital and voting rights, allowing stakeholders to stay informed about their investment. This information is crucial for understanding the overall health of the company and its governance structure.
Share Capital Overview
As of a specified date, Virbac reported a total of 8,390,660 shares that represent its share capital. This figure is essential, as it reflects the overall equity available to shareholders in the market. Additionally, it is worth noting that the company is listed on Euronext Paris, where it trades under the code ISIN: FR0000031577.
The Importance of Voting Rights
Alongside the total share count, the total number of voting rights is a vital component that shareholders must consider. Virbac has reported a gross total of 12,715,985 voting rights attributed to its shares. This provides investors with insights into the extent of their influence on corporate decisions, highlighting the democratic aspect of shareholding.
Net Voting Rights Breakdown
It is also important to differentiate between gross and net voting rights. The net total number of voting rights stands at 12,699,919, reflecting the active shares after excluding any shares that do not carry voting rights. This distinction is critical for investors who want to assess their actual voting power within the company.
Commitment to Transparency
Virbac’s structured disclosure of such information aligns with its commitment to transparency and governance best practices within the animal health industry. By regularly updating its shareholders, Virbac ensures that all stakeholders can make informed decisions regarding their investments.
In addition to financial aspects, the company is also dedicated to innovation in animal health, focusing on research and development to provide enhanced healthcare solutions for pets and farm animals worldwide.
Corporate Governance
Good corporate governance is fundamental to Virbac’s operations. By providing clear communication regarding voting rights and share capital, the company fosters trust and encourages active participation among its shareholders. This approach not only strengthens shareholder engagement but also reinforces the company's reputation as a socially responsible entity.
Contact Information for Stakeholders
For stakeholders seeking further information, Virbac offers comprehensive support. You can reach the corporate finance department at +33 4 92 08 71 32 or via email at finances@virbac.com. Their website, www.virbac.com, also provides additional resources and updates regarding the company’s operations and commitments.
Frequently Asked Questions
1. What is the total number of Virbac’s shares as of the latest update?
Virbac has reported a total of 8,390,660 shares representing its capital.
2. How many voting rights are attached to Virbac’s shares?
The gross total of voting rights is 12,715,985, with a net total of 12,699,919 voting rights.
3. Why is the distinction between gross and net voting rights important?
This distinction allows shareholders to understand the actual influence they have in the company's decision-making processes.
4. How can shareholders obtain information about Virbac?
Shareholders can contact the corporate finance department at +33 4 92 08 71 32 or through the email finances@virbac.com.
5. In which market is Virbac listed?
Virbac is listed on the Euronext Paris under the ISIN code FR0000031577.